Innophos increases focus on dietary supplements through $125m acquisition of Novel Ingredients
The NASDAQ-traded firm Innophos Holdings has entered into a definitive merger agreement to acquire Novel Ingredients for $125m, bumping up the share of its food, health, and nutrition segment within the company.